Zhenghai Biology: Calcium-silicate biological ceramic bone repair materials are expected to be approved within the year.

On May 13th, during an institutional research, China Fishery Group stated that in terms of research and development, the company continues to enhance its product industrialization capabilities and strives to obtain approval for more new products. In January of this year, the company's second-generation oral repair film has been approved, and the calcium-silicon bio-ceramic bone repair material is expected to be approved within the year, which will help enrich the company's product matrix in the field of oral care. Other products in the clinical stage include uterine repair films and breast patches, which, once launched, will expand the company's downstream application departments to include gynecology, obstetrics, breast surgery, and so on.